All In Biotech

Drug Trial Radar · NCT00925054

Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU

Phase 2, Open-Label Dose-Finding Study to Evaluate the Safety, Efficacy, and Tolerability of Multiple Subcutaneous (SC) Doses of rAvPAL-PEG in Subjects With PKU

Last checked: Nov 20, 2026Latest source record: Feb 26, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

40

Actual

Start

Sep 2009

Primary completion

Jun 2015

Study completion Jun 2015

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Jun 19, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 16 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate whether weekly injections of phenylalanine ammonia lyase (rAvPAL-PEG) can reduce blood phenylalanine concentrations in PKU subjects and whether repeated administration is safe.

Conditions

  • Phenylketonuria

Interventions

  • rAvPAL-PEG 0.001 mg/kgDrug

    In Part 1, the planned starting dose levels is 0.001 mg/kg

  • rAvPAL-PEG 0.003 mg/kgDrug

    In Part 1, the planned starting dose levels is 0.003 mg/kg

  • rAvPAL-PEG 0.01 mg/kgDrug

    In Part 1, the planned starting dose levels is 0.01 mg/kg

  • rAvPAL-PEG 0.03 mg/kgDrug

    In Part 1, the planned starting dose levels is 0.03 mg/kg

  • rAvPAL-PEG 0.1 mg/kgDrug

    In Part 1, the planned starting dose levels is 0.1 mg/kg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blood Phenylalanine ConcentrationsTime frame: Baseline, Week 1/Day 5, Week 7, Week 16/Day 106

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • The Children's Hospital

    Aurora, Colorado

  • Emory Universty

    Decatur, Georgia

  • Children's Memorial Hospital

    Chicago, Illinois

  • University of Minnesota Medical Center-Fairview

    Minneapolis, Minnesota

  • Washington University Center for Applied Research Sciences

    St Louis, Missouri

  • Albany Medical Center

    Albany, New York

  • Mount Sinai School of Medicine

    New York, New York

  • Akron Children's Hospital

    Akron, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • University of Utah Hospital

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.